EVIIVE

EVIIVE is a Swiss biotech company pioneering the next generation of blood-based diagnostics through high-dimensional analysis of extracellular vesicles (EVs). Spun out from research at the University of Zurich, it has built a proprietary platform that profiles single EVs with exceptional resolution, revealing real-time immune dynamics that traditional biomarkers miss. The technology works from a small volume of plasma, enabling non-invasive diagnostics with clinical-grade performance. EVIIVE aims to unlock the immune system's hidden signals to guide more precise, personalized treatment decisions, starting with immunotherapy in cancer, and is advancing toward clinical implementation with pharma and academic partners.